Anaesthetic management of a pregnant patient posted for emergency appendicectomy
anaesthesia pregnant non-obstetric surgery appendectomy
| Step | Action |
|---|---|
| History | Gestational age, last oral intake, symptoms (severity, duration), medications, allergies |
| Examination | Airway assessment (Mallampati, neck mobility, mouth opening), baseline vitals, fetal viability assessment |
| Investigations | FBC, UEC, LFT, CRP, coagulation, crossmatch, ABG if respiratory compromise; CTG (>24 weeks) |
| OB consultation | Mandatory - plan for intraoperative/postoperative fetal monitoring, readiness for emergency delivery |
| Consent | Risks of anaesthesia to mother and fetus; risk of preterm labour (highest with abdominal surgery) |
| Drug | Dose | Notes |
|---|---|---|
| Propofol | 2-2.5 mg/kg IV | Induction agent of choice; haemodynamic monitoring |
| OR Thiopentone | 4-5 mg/kg IV | Traditional RSI agent; still acceptable |
| OR Ketamine | 1-2 mg/kg IV | Use if haemodynamically compromised; maintains uteroplacental perfusion |
| Succinylcholine | 1.5 mg/kg IV | Neuromuscular blockade for RSI; onset 45-60 sec; reduced pseudocholinesterase has minimal clinical impact |
| OR Rocuronium | 1.2 mg/kg IV | Acceptable alternative if succinylcholine contraindicated; sugammadex reversal possible |
| Agent | Comments |
|---|---|
| Paracetamol | Safe in all trimesters; first-line |
| Regional techniques (TAP block, wound infiltration, epidural) | Preferred; reduces systemic opioid exposure |
| Opioids (morphine, fentanyl) | Safe for acute use; reduces FHR variability; neonate may need respiratory support if delivered soon after |
| NSAIDs | Avoid before 20 weeks (miscarriage risk) and after 30 weeks (premature closure of ductus arteriosus, oligohydramnios); limited use between 20-30 weeks only for refractory pain |
| Avoid | Codeine (variable metabolism, neonatal risk), high-dose aspirin |
| Trimester | Key Points |
|---|---|
| 1st (0-13 wk) | Organogenesis complete by week 8-10; avoid teratogens; no aortocaval compression concern; RSI less critical but aspiration risk still present; miscarriage risk with abdominal surgery |
| 2nd (14-27 wk) | Safest period for surgery; organogenesis complete; lower preterm labour risk than 3rd trimester; aortocaval compression begins ~18-20 wk; RSI standard from mid-2nd trimester |
| 3rd (28-40 wk) | Highest aspiration risk; most pronounced physiological changes; highest preterm labour risk; full RSI mandatory; consider delivery readiness; FDA warning on prolonged GA exposure for fetal brain development |